AIRLINK 70.80 Decreased By ▼ -2.26 (-3.09%)
BOP 4.99 Decreased By ▼ -0.10 (-1.96%)
CNERGY 4.33 Decreased By ▼ -0.04 (-0.92%)
DFML 31.37 Decreased By ▼ -1.08 (-3.33%)
DGKC 77.01 Increased By ▲ 1.52 (2.01%)
FCCL 20.01 Increased By ▲ 0.49 (2.51%)
FFBL 35.02 Decreased By ▼ -1.13 (-3.13%)
FFL 9.15 Decreased By ▼ -0.07 (-0.76%)
GGL 9.89 Increased By ▲ 0.04 (0.41%)
HBL 113.49 Decreased By ▼ -3.21 (-2.75%)
HUBC 132.60 Decreased By ▼ -0.09 (-0.07%)
HUMNL 7.07 Decreased By ▼ -0.03 (-0.42%)
KEL 4.34 Decreased By ▼ -0.07 (-1.59%)
KOSM 4.34 Decreased By ▼ -0.06 (-1.36%)
MLCF 36.71 Increased By ▲ 0.51 (1.41%)
OGDC 133.90 Increased By ▲ 0.40 (0.3%)
PAEL 22.50 Decreased By ▼ -0.10 (-0.44%)
PIAA 24.88 Decreased By ▼ -1.13 (-4.34%)
PIBTL 6.52 Decreased By ▼ -0.03 (-0.46%)
PPL 117.15 Increased By ▲ 1.84 (1.6%)
PRL 26.37 Decreased By ▼ -0.26 (-0.98%)
PTC 13.80 Decreased By ▼ -0.30 (-2.13%)
SEARL 52.52 Decreased By ▼ -0.93 (-1.74%)
SNGP 69.40 Increased By ▲ 2.15 (3.2%)
SSGC 10.68 Decreased By ▼ -0.02 (-0.19%)
TELE 8.45 Increased By ▲ 0.03 (0.36%)
TPLP 10.90 Increased By ▲ 0.15 (1.4%)
TRG 61.48 Decreased By ▼ -2.39 (-3.74%)
UNITY 25.00 Decreased By ▼ -0.12 (-0.48%)
WTL 1.29 Increased By ▲ 0.02 (1.57%)
BR100 7,448 Decreased By -12.8 (-0.17%)
BR30 24,129 Decreased By -42 (-0.17%)
KSE100 71,136 Increased By 33.6 (0.05%)
KSE30 23,397 Increased By 2 (0.01%)
World

Mexico receives 1.5mn does of AstraZeneca COVID-19 vaccine from US

  • The vaccines were the initial batch in an agreement to send some 2.7 million AstraZeneca doses from the United States.
Published March 29, 2021

MEXICO CITY: A delivery of 1.5 million doses of AstraZeneca's COVID-19 vaccine from the United States landed in Mexico City on Sunday night, Mexico's foreign ministry said, following an accord US President Joe Biden made with Mexico this month.

The vaccines were the initial batch in an agreement to send some 2.7 million AstraZeneca doses from the United States to help Mexico offset local shortages for its drive to inoculate iits population of 126 million.

Comments

Comments are closed.